False Claims Act & Government Investigation Defense

We successfully defend clients in False Claims Act investigations and litigation, while also helping them strengthen their internal compliance programs to avoid future litigation.


Our False Claims Act Defense attorneys have decades of experience successfully defending government contractors, healthcare providers, pharmaceutical companies, and other companies in investigations and litigation alleging violations of the Anti-Kickback Statute and the False Claims Act and Medicare and Medicaid fraud. We have successfully defended dozens of corporations, hospitals, and physicians against qui tam or whistleblower claims, investigated and litigated by the U.S. Department of Justice (DOJ) in jurisdictions nationwide.

We help our clients protect themselves by strengthening their internal compliance programs. This includes incorporating a culture of compliance throughout the company, making reporting procedures readily accessible to employees, protecting privileged communications, and ensuring prompt investigations and, where necessary, prompt redress of legitimate employee reports. Our attorneys have extensive experience developing and implementing specialized compliance programs for our clients.

Our team includes former Assistant United States Attorneys, OIG enforcement counsel, and other former senior government attorneys.

Additional Specialties


  • Represented a national nursing home chain and obtained a favorable settlement in False Claims Act case alleging that two national nursing home chains and their principals conspired to solicit a $50 million kickback from a large national pharmaceutical supply company in exchange for continuing to provide pharmacy services to the homes.
  • Represented a large public company in a $100+ million False Claims Act investigation related to contracts for the provision of goods to the U.S. Military, obtaining a favorable settlement after internal investigation and presentation to the government.
  • Represented two large publicly traded nursing home companies in a Department of Justice investigation of reimbursements for therapy provided at nursing homes.
  • Represented a major regional hospital in a nationwide Department of Justice investigation related to implantable cardiac defibrillators.
  • Represented one of the largest specialty medical practices in the Southeast in an investigation by the U.S. Attorney’s Office alleging improper modifier 25 billing.
  • Represented national pediatric care provider in joint state and federal False Claims Act investigation related to documentation of care provided and reverse false claims allegations.
  • Represent a cardiology practice in a Department of Justice investigation related to the implantation of cardiac stents.
  • Represented multiple hospices in False Claims Act investigation related to the eligibility of patients for hospice care.

    News & Insights